These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 75603)

  • 21. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 23. [Administration of afala preparation in urological practice].
    Neĭmark AI; Isaenko VI; Iakovets IaV; Simashkevich AV; Aliev RT
    Urologiia; 2009; (3):67-70. PubMed ID: 19673125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone therapy of the so-called prostate adenoma. (Experiments with progesterone)].
    BUDNIOK R
    Dtsch Gesundheitsw; 1951 Oct; 6(40):1131-3. PubMed ID: 14887409
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vitaprost forte efficacy in patients with prostatic adenoma].
    Tkachuk VN; Tkachuk IN
    Urologiia; 2008; (4):34-7. PubMed ID: 19058362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benign prostatic hyperplasia--botulinum toxin A in BPH with small prostate volume].
    Adler S
    Aktuelle Urol; 2006 Sep; 37(5):315-6; discussion 315-6. PubMed ID: 17004177
    [No Abstract]   [Full Text] [Related]  

  • 27. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestin binding in benign hyperplastic prostatic tissue.
    Sirett DA
    J Steroid Biochem; 1983 Jul; 19(1A):163-7. PubMed ID: 6193339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrinologic aspects of benign prostatic hyperplasia (prostatic adenoma). (Can hormone therapy of the disease be justified in 1984?)].
    Holló I; Horváth C
    Orv Hetil; 1984 Oct; 125(44):2675-8. PubMed ID: 6208526
    [No Abstract]   [Full Text] [Related]  

  • 31. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 32. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of benign prostatic hyperplasia concentrates on early stages].
    Hofstetter A
    Fortschr Med; 1997 Feb; 115(5):8. PubMed ID: 9162723
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of vitaprost forte in patients with prostatic adenoma].
    Miller AM; Iaroshenko VP; Soroka PV; Stakhnev EIu
    Urologiia; 2008; (5):50, 52-4. PubMed ID: 19069497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.
    Story MT; Hopp KA; Meier DA
    Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progestogen therapy of benign prostatic hypertrophy].
    Nakayama K; Okamoto K
    Hinyokika Kiyo; 1970 Sep; 16(9):558-60. PubMed ID: 4097367
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experience with SH 582 for prostatic hypertrophy].
    Kobayashi C; Miki M
    Hinyokika Kiyo; 1970 Sep; 16(9):446-9. PubMed ID: 4097358
    [No Abstract]   [Full Text] [Related]  

  • 38. [Urine flowmetry in patients with prostatic adenoma treated with Raveron].
    Steinmetz L; Adamkiewicz K
    Pol Przegl Chir; 1974 Oct; 46(10A):1375-82. PubMed ID: 4139698
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-operative treatment of benign prostatic hyperplasia.
    Lal MM; Jain S
    J Indian Med Assoc; 1980 Nov; 75(9):174-6. PubMed ID: 6164733
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical effects of SH 582 (gestonorone caproate) on benign prostatic hypertrophy].
    Momose S; Hidaka M; Oota Y; Oomaru K
    Hinyokika Kiyo; 1970 Sep; 16(9):551-4. PubMed ID: 4097366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.